Xafinact 50mg
| SKU | 2629 |
|---|---|
| Generic For | Xadago |
| Manufacturer | Sun Pharmaceuticals Ltd |
| Active Ingredient | Safinamide |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.68 | US$ 20.40 | |||
|
|||||
| 60 Tablet/s | US$ 0.61 | US$ 36.7210%US$ 40.80 | |||
|
|||||
| 90 Tablet/s | US$ 0.47 | US$ 42.0031%US$ 61.20 | |||
|
|||||
Xafinact 50mg (Safinamide) – Affordable Xadago Alternative
Xafinact 50 mg is a prescription treatment for adult patients with idiopathic Parkinson's disease as an add-on therapy to a stable dose of levodopa. It contains the active ingredient safinamide, which increases dopamine levels in the brain. Dopamine is a chemical substance that helps control movement and is present in reduced amounts in the brains of patients with Parkinson's.
Xafinact use in patients with severe hepatic impairment is contraindicated. No dose adjustment is required in patients with mild hepatic impairment. A lower dose of 50 mg per day is recommended for patients with moderate liver insufficiency. If a patient progresses from severe liver insufficiency, Xafinact should be stopped.
The medicine is contraindicated in patients with hypersensitivity to the active substance or any of the ingredients in the medicine. It should not be given to patients with retinal degeneration, albinism, inherited retinopathy, or severe progressive diabetic retinopathy. Safinamide should not be used with other monoamine oxidase inhibitors and pethidine. Do not take this medicine if you have an eye condition that might put you at risk of potential damage to your retina.
The medicine should not be given to women of childbearing potential until adequate contraception is taken. A risk for the breastfed child can't be excluded. This medication should not be used during breastfeeding.
Dizziness may occur during Xafinact treatment; therefore, patients should be cautioned about using hazardous machines, including motor vehicles, until they are reasonably certain that the medication does not affect them adversely.
Common side effects of Xafinact 50 mg are feeling sleepy, headache, difficulty in performing voluntary movements, headache, dizziness, worsening of Parkinson's disease, nausea, falling, fall in blood pressure when rising to a standing position, and clouding of the lens of the eye.
Treatment with Xafinact should be started at 50 mg per day. This daily dose may be increased to 100 mg per day based on individual requirements. For oral use, Xafinact should be taken with water. Safinamide may be taken before or after consuming food. If you miss a dose, be sure to take the next dose at the usual time the next day. No dose adjustment is required for elderly patients. Use of s safinamide in patients over 75 years of age is limited.
What is Safinamide and what condition does it treat?
Safinamide is the active ingredient in Xafinact 50mg, a prescription medication used to treat Parkinson's disease. This neurological treatment belongs to a class of drugs known as monoamine oxidase B (MAO-B) inhibitors. It's specifically prescribed as an add-on therapy for patients already taking levodopa who experience motor fluctuations or "off" episodes. Xafinact helps improve movement control, reduce stiffness, and manage tremor symptoms associated with this progressive neurological disorder. The medication works alongside existing Parkinson's treatments to provide more consistent symptom relief throughout the day.
How does Safinamide work in the body?
Safinamide, the active compound in Xafinact 50mg, works through a dual mechanism to manage Parkinson's disease symptoms. As a selective MAO-B inhibitor, it blocks the enzyme that breaks down dopamine in the brain, helping maintain higher dopamine levels for improved motor function. Additionally, this Parkinson's medication modulates glutamate release by affecting sodium and calcium channels, which provides further neuroprotective benefits. This two-pronged approach helps smooth out motor fluctuations and extends the effectiveness of levodopa therapy. By preserving dopamine availability and balancing other neurotransmitters, Xafinact supports more stable movement control throughout the day.
How long does Xafinact 50mg take to work?
Xafinact 50mg typically begins showing therapeutic effects within two to four weeks of consistent daily use. As an adjunct Parkinson's treatment containing safinamide, this medication requires time to build up steady levels in your system and optimize dopamine regulation. Some patients notice gradual improvements in motor fluctuations and reduced "off" time within the first fortnight, while full benefits often emerge after four to six weeks. The timeline varies individually based on disease progression and concurrent medications. This MAO-B inhibitor works progressively rather than providing immediate relief, so patience and adherence to your prescribed regimen are essential for optimal results.
When and how should I take Xafinact 50mg?
Take Xafinact 50mg once daily at the same time each day, with or without food. Swallow the tablet whole with water without crushing or chewing it. This Parkinson's medication containing safinamide is typically taken in the morning to complement your levodopa therapy. Consistency in timing helps maintain stable drug levels for better motor symptom control. Your doctor may start you on a lower dose and increase it based on your response. Avoid tyramine-rich foods in large quantities while taking this MAO-B inhibitor, and inform your healthcare provider about all medications you're taking to prevent potential interactions.
Is Xafinact 50mg safe for long-term use?
Xafinact 50mg containing safinamide is designed for long-term management of Parkinson's disease when used as prescribed. Clinical studies have demonstrated acceptable safety profiles over extended periods as an adjunct therapy with levodopa. This MAO-B inhibitor has been evaluated for continuous use in ongoing treatment regimens. Long-term safety depends on regular monitoring of your condition, periodic medical reviews, and appropriate dose adjustments as needed. Like all Parkinson's medications, extended use requires balancing therapeutic benefits against potential risks, which your neurologist will assess during follow-up appointments. Most patients tolerate this neurological treatment well over prolonged periods.
Can I take Xafinact 50mg with other medicines?
Xafinact 50mg can interact with several medications, so a comprehensive medication review is essential before starting this safinamide-based treatment. This MAO-B inhibitor should not be combined with other monoamine oxidase inhibitors, certain antidepressants (especially SSRIs and SNRIs), opioid pain medications like meperidine or tramadol, or the cough suppressant dextromethorphan. Combining these with Xafinact may cause serious reactions including serotonin syndrome. It's specifically designed to work alongside levodopa for Parkinson's disease, but always disclose all prescription drugs, over-the-counter medicines, and supplements to your healthcare provider to ensure safe concurrent use.
How does Xafinact 50mg compare to similar medicines in its class?
Xafinact 50mg stands out among MAO-B inhibitors through its unique dual-action mechanism. While other medications in this class like rasagiline and selegiline primarily inhibit dopamine breakdown, safinamide also modulates glutamate activity, providing additional neuroprotective effects for Parkinson's disease management. This adjunct therapy offers comparable dopamine-preserving benefits with a potentially different tolerability profile. Xafinact is taken once daily like its counterparts but may offer advantages in managing motor fluctuations when combined with levodopa. Each medication in this category has distinct characteristics, and selection depends on individual patient factors, concurrent treatments, and specific symptom patterns observed in your condition.
Is the generic Safinamide as effective as branded versions?
Generic safinamide contains the identical active ingredient as branded Xafinact 50mg and must demonstrate bioequivalence to receive regulatory approval. This means the generic Parkinson's medication delivers the same therapeutic effects, with the active compound absorbed and utilized by your body in an equivalent manner. Regulatory authorities require generic MAO-B inhibitors to meet rigorous standards ensuring they perform comparably to brand-name versions. The primary differences lie in inactive ingredients, packaging, and cost rather than clinical effectiveness. Both branded and generic formulations provide the same dopamine-regulating benefits for managing motor fluctuations in Parkinson's disease when used as adjunct therapy.
Why do patients choose PremiumRxDrugs for Xafinact 50mg?
Patients select PremiumRxDrugs for their Xafinact 50mg because we combine affordability with authenticity for this essential Parkinson's medication. The pharmacy's competitive pricing on safinamide makes long-term treatment more manageable financially without compromising on quality—all medications are manufacturer-sourced and genuine. Our international shipping reaches patients in the USA, UK, Australia, and Canada with discreet packaging that respects your privacy. The easy prescription management system simplifies reorders for this daily MAO-B inhibitor therapy. Having earned patients' trust for over 10 years, PremiumRxDrugs offers the reliability needed to manage chronic neurological conditions, backed by responsive customer support and secure transactions.
What are the common side effects of Safinamide?
Common side effects of safinamide include involuntary movements (dyskinesia), falls, nausea, and insomnia. Some patients taking this MAO-B inhibitor experience orthostatic hypotension (dizziness upon standing), headache, or anxiety. Digestive issues like constipation or decreased appetite may occur as your body adjusts to this Parkinson's medication. Visual disturbances and increased blood pressure have been reported less frequently. Many side effects are mild and diminish as treatment continues, though dyskinesia sometimes requires dose adjustment of concurrent levodopa therapy. Serious reactions are uncommon but can include sudden sleep onset, hallucinations, or impulse control problems. Most patients tolerate this adjunct therapy well.
Who should avoid taking Safinamide?
Safinamide should be avoided by individuals with severe liver disease, as this MAO-B inhibitor is metabolized hepatically. People taking other monoamine oxidase inhibitors, certain antidepressants (SSRIs, SNRIs, tricyclics), or specific opioids should not use this Parkinson's medication due to dangerous interaction risks. Patients with albinism, retinal problems, uveitis, or inherited retinal conditions should avoid safinamide because of potential vision-related risks. It's contraindicated during pregnancy and breastfeeding due to insufficient safety data. Those with uncontrolled hypertension require careful evaluation before starting this treatment. Anyone with a history of impulse control disorders or psychotic episodes needs thorough assessment before beginning this neurological therapy.
Login
Sign Up
Login
Sign Up